Form D · Other Health Care
Conceivable Life Sciences Inc.
New York, NY · CIK 0001986248
Offering snapshot reported Sep 15, 2025 · SEC filing
- Reported sold
- $30.5M Offering amount: $33M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Aug 5, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 15, 2025 | Initial | $30,499,997 | No comparison | 20 | SEC filing |
| Jan 2, 2025 | Amendment | $15,997,162 | $900,000vs Dec 17, 2024 | 18 | SEC filing |
| Dec 17, 2024 | Initial | $15,097,162 | No comparison | 17 | SEC filing |
| Jul 20, 2023 | Initial | $16,975,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-557503
Includes amounts paid in both cash and pursuant to conversion of existing indebtedness.
Source: Form D, filed Sep 15, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joshua Abram | Director, Executive |
| Alejandro Chavez Badiola | Director, Executive |
| Alex Christ | Director |
| Fred Destin | Director |
| Aike Ho | Director |
| Alan Murray | Director, Executive |
| Stuart Peterson | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
160 Mercer Street 3 Rd Floor
New York, NY, 10012
New York, NY, 10012